Latest News and Press Releases

Oslo, Norway, April 9, 2019 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2018 and the report is attached. The Annual Report 2018 is also available on the...

Oslo (Norway), 8 April 2019 – PCI Biotech (OSE: PCIB), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced final...

Oslo (Norway), 28 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that its Chief Business Development Officer (CBDO), Gaël L’Hévéder has resigned...

Oslo, Norway, 25 February 2019. Reference is made to the previous announcements by PCI Biotech Holding ASA ("PCI Biotech" or the "Company") in respect of the issuance of 61,000 new shares following...

Oslo (Norway), 20 February 2019 – Exercise of employee share options, mandatory notification of trade and resolution to increase the share capital in PCI Biotech Holding ASA (the “Company”). 1.  ...

Oslo (Norway), 13 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim fourth quarter and preliminary 2018 result. Please find enclosed the...

Oslo, Norway, 05 February 2019 - PCI Biotech invites to a presentation of the company's fourth quarter and preliminary 2018 report on Wednesday 13 February 2019 at Oslo Cancer Cluster Innovation Park....

Oslo (Norway), 20 December 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced preliminary confirmation that the safety endpoint has been reached in the Phase I...

Oslo (Norway), 18 December 2018 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that they are extending the preclinical research collaboration with an undisclosed...

Oslo (Norway), 13 November 2018 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its interim third quarter 2018 result. Please find enclosed the report and...